Edap Tms (EDAP) to Release Earnings on Thursday

Edap Tms (NASDAQ:EDAP) is scheduled to be releasing its earnings data before the market opens on Thursday, November 7th. Analysts expect Edap Tms to post earnings of ($0.16) per share for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings results on Wednesday, August 28th. The medical equipment provider reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.04). Edap Tms had a negative return on equity of 36.41% and a negative net margin of 31.68%. The company had revenue of $16.97 million for the quarter, compared to analysts’ expectations of $17.16 million. On average, analysts expect Edap Tms to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Edap Tms Stock Performance

NASDAQ EDAP traded up $0.09 on Tuesday, hitting $2.78. 2,802 shares of the stock traded hands, compared to its average volume of 45,931. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.80 and a current ratio of 2.45. The business’s fifty day moving average is $2.91 and its two-hundred day moving average is $4.60. Edap Tms has a 12 month low of $2.27 and a 12 month high of $8.50. The firm has a market capitalization of $103.15 million, a price-to-earnings ratio of -4.64 and a beta of 0.38.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the company. HC Wainwright reiterated a “buy” rating and set a $19.00 price target on shares of Edap Tms in a research note on Thursday, August 29th. StockNews.com upgraded shares of Edap Tms from a “sell” rating to a “hold” rating in a research report on Wednesday, September 25th.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.